EurekAlert! -
27 Apr 2021 06:00
(Drugs for Neglected Diseases Initiative) The ANTICOV clinical trial, conducted in 13 African countries, has started the recruitment of participants to test a new drug combination to treat people with mild-to-moderate COVID-19 before their cases become severe. ANTICOV is the largest trial in Africa focusing on people with mild COVID-19.
Share this Article